G20.1
Conditions
Interventions
Group 1: Two independent longitudinal trail phases will be conducted on different study populations. In trail phase 1, continuously home-monitoring with a mobile gait analysis system over a 2 week per
Sponsors
Universitätsklinikum Erlangen, Molekular-Neurologische Abteilung
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Diagnosis of a Parkinson syndrome in accordance with the guideline of the German Society of Neurology (Hoehn & Yahr stadium I-III) - Ability to walk for 2 Minutes without assistance - Ability to speak and read - Ability to use an application running on a smart device - informed consent with understanding of the study procedures
Exclusion criteria
Exclusion criteria: - Aphasia and Alexia - Impaired vision which makes reading unfeasible - Regular use of gait aids - Decompensated cardiopulmonary restrictions - Maximal walking distance < 100 meter - Inability to understand the informed consent and the study procedures - Distinct musculoskeletal disorder, which highly restricts movement and gait abilities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Retrospective classification of patients into fall risk categories regarding sensor-based gait parameters continuously recorded over a 2 weeks period in home environments. 2. Prospective identification of the fall risk sensor-based gait parameters continuously recorded over a 4 weeks period in home environments. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Frequency of falls in pre-, post- and follow up-assessments. 2. Fear of falling in pre-, post- and follow up-assessments. | — |
Countries
Germany
Contacts
Public ContactTill Gladow
Molekulare Neurologie, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg
Outcome results
None listed